Product logins

Find logins to all Clarivate products below.


Gynecological Devices | Market Insights | US | 2019

Growth in the US market for gynecological devices will be driven primarily by product improvements in the GEA device, hormonal IUD, and hysterscopic morcellator markets. The market will also be fueled by the adoption of devices used in office-based procedures—including hormonal ARC devices, GEA devices, fluid management devices, and hysteroscopic morcellators—due to growing awareness of less invasive treatment options for various gynecological conditions. The market will be limited by safety issues that lead to product recalls of major products on the market. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for gynecological devices in the US across a 10-year period.

Related Medtech Insights Reports

Report
Gynecological Devices – Market Insights – Asia Pacific
Driven by the rising prevalence of gynecological diseases and aging population in this region, the Asia Pacific gynecological device market will continue to witness modest growth through 2034…
Report
Gynecological Devices – Market Insights – Japan
The Japanese gynecological device market will experience slow but steady growth over the forecast period, driven primarily by increasing awareness among women regarding gynecological health and…
Report
Gynecological Devices – Market Insights – Europe (Supplemental)
The European gynecological device market will see marginal growth over the forecast period. This growth will be driven by the continued adoption of technologies that enable treatments in office-…
Report
Gynecological Devices – Market Insights – United States
Growth in the US market for gynecological devices will be driven by various factors including the aging female population (and corresponding increase in treatments for incontinence and AUB), ARC…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period. This growth will be driven by the continued adoption of technologies that enable treatments in office-…